Archive | Health Areas

RSS feed for this section

Rapport de quantification des produits de la santé reproductive, maternelle, néonatale et infantile pour la période de janvier 2017 à décembre 2020

La présente activité avait pour objectif d’apporter un soutien au Ministère de la Santé et de l’Hygiène publique (MSHP) pour la quantification des besoins en médicaments pour la santé reproductive, maternelle, néonatale et infantile (SRMNI). C’est ainsi que la Direction de la pharmacie et du médicament, à travers l’appui technique et financier de SIAPS, a organisé un atelier pour quantifier les besoins en ces produits. Grâce à la participation de tous les principaux intervenants, un plan d’approvisionnement a été élaboré dans le but d’établir les besoins prévisionnels pour la période s’échelonnant de 2017 à 2020. Les résultats de cet exercice de quantification seront utilisés dans la planification pour mobiliser et obtenir des ressources financières pour ladite période. Aux fins de cet exercice de quantification, la méthode basée sur la morbidité a été utilisée. La prévision des besoins a été faite pour l’ensemble du pays sur la base d’une liste des produits utilisés dans la prise en charge de la femme, du nouveau-né et de l’enfant.

Read full story · Comments are closed

Adopting the Pharmacovigilance Monitoring System for the Philippines National Tuberculosis Program

The Department of Health-Pharmaceutical Division (DOH-PD) and National TB Program (NTP) in the Philippines adopted the web‐based application Pharmacovigilance Monitoring System (PViMS) to ensure systematic data collection and simplify the analysis of medicine safety information. PViMS is a free web tool developed by SIAPS to help clinicians, regulatory bodies, and implementing partners monitor medicine safety, specifically in resource-limited countries. The SIAPS Program works to improve the availability and quality of information for decision making through the use of electronic tools combined with systems strengthening.

 

Read full story · Comments are closed

Process of implementing e-TB Manager, 2008-2016: a summary of 10 countries

multicountry user experience analysis of e-TB Manager and an in-depth study in Ukraine were published. However, the procedural aspects of e-TB Manager implementation in each country were not documented. While facilitators and barriers for eHealth implementation in resource-constrained settings are well known, the objective of this paper is to summarize the tailored implementation approaches given local context, which is a crucial consideration. The paper summarizes the key lessons learned and implications for other electronic health information systems.

Read full story · Comments are closed

Lucky Specials Brings Focus to TB Awareness Week in Namibia

Theresia Cloete was diagnosed with tuberculosis (TB) in 2002. She was put on treatment but after four months stopped taking her TB medication. Last year, she was diagnosed with drug-resistant TB. Like Cloete, many TB patients stop taking their life-saving medication before they are cured. She is now one of eight in-patients waiting for stabilization […]

Read full story · Comments { 0 }

Quality and Safety of HIV/AIDS Medicines in Namibia October 2015-September 2016

In the last five years, SIAPS has provided technical assistance to the Namibia Medicines Regulatory Council (NMRC) to strengthen its capacity for registration and quality testing by training technical staff in medicines dossier evaluation, developing guidelines for conducting the routine PMS of quality of medicines, and collecting medicine samples at selected ART and TB treatment sites for laboratory testing. SIAPS mentored and provided guidance and technical support to NMRC staff and other personnel in conducting efficient dossier reviews for the registration of ARVs, anti-TB, and other essential medicines. Consequently, intensive dossier review sessions were organized and fully funded by NMRC after effective and successful transition of the activity to NMRC for sustainability. SIAPS provided technical assistance to the NMRC to develop guidelines and collect medicine samples from seven priority regions (Kavango East and West, Khomas, Ohangwena, Omusati, Oshana, Oshikoto, and Zambezi) and one urban hotspot (Grootfontein [Otjozondjupa]).

Read full story · Comments are closed

Assessment of the Neglected Tropical Diseases Pharmaceutical Management System in Senegal

Supply chain constraints plague current neglected tropical disease (NTD) prevention and treatment programs. The rapid expansion of NTD control activities has not been without pharmaceutical and health system challenges. Inadequate NTD drug management in many countries has resulted in excess stocks, leading to waste resulting from drug expiry or stock-outs, leading to treatment interruption. SIAPS has received funding from USAID to support the Senegal MoH in strengthening the systems for NTD pharmaceutical management. The purpose of the technical assistance is to undertake a rapid assessment of the NTD pharmaceutical management system and understand the integration efforts. Technical review and recommendations have been provided by SIAPS personnel based in the SIAPS West Africa Offices and the office in Arlington, Virginia. SIAPS held meetings with the MoH NTD focal points and supply chain managers to ensure efficient delivery of technical support to the NTD programs, cross fertilization, sharing of lessons learned, challenges, and recommendations and to ensure that the implemented interventions are of the highest technical quality that focuses on country objectives.

Read full story · Comments are closed

Registration and Quality Assurance of ARVs and other Essential Medicines in Namibia

SIAPS provided technical assistance to facilitate the expedited assessment and registration of new and existing ARV formulations to support the implementation of the revised Namibian ART guidelines (dated January 2014). The technical assistance focused on improving the efficiency of the regulatory system so that the recommended new first-line fixed-dose combination ARVs that contain tenofovir and emtricitabine for adults; optimized ARV formulations for pediatric use; and other medicines for HIV and AIDS; TB; maternal, newborn, and child health (MNCH); and other public health diseases are assessed and considered for registration and made available for public procurement in a timely manner to benefit patients undergoing ART.

Read full story · Comments are closed

Strengthening Registration and Quality Assurance Systems for Generic ARVs, Related Medicines, and Devices in Namibia

In Namibia, USAID has been providing funding for technical assistance in the areas of pharmaceutical management and systems strengthening since 2003. During this period, the Rational Pharmaceutical Management Plus (RPM Plus) and Strengthening Pharmaceutical Systems (SPS) programs were implemented. RPM Plus supported interventions that largely focused on strengthening systems for the antiretroviral therapy (ART) and prevention of mother-to-child transmission of HIV programs. SPS focused on strengthening systems based on World Health Organization (WHO) building blocks, increasing the number of pharmaceutical personnel available for service delivery, strengthening policy coordination, and improving the regulatory functions of the NMRC. SIAPS focuses on further strengthening of regulatory and management systems in the pharmaceutical sector under the governance and health systems strategic area to support HIV and AIDS and other public health services.

Read full story · Comments are closed

Mapping the Financial Flow and Expenditures for Select MNCH Medicines in Uganda

Since the report of the United Nations Commission on Life-saving Commodities for Women and Children (UNCoLSC) was published in 2012, much has been done to highlight the challenges countries face in ensuring the availability of essential commodities and to create resources to assist countries in this endeavor. In most settings, these commodities are procured with government funds, but there is a lack of documented evidence as to how decisions regarding financing for these commodities are made and executed. An understanding of the financial flows for MNCH commodities is critical as countries pursue the goals of ending preventable child and maternal deaths and of universal health coverage and as many go through processes of decentralization. Understanding financial flows for MNCH commodities may also assist the donor community in making smarter investments and assisting countries in mobilizing additional resources. The US Agency for International Development (USAID) commissioned this study in Bangladesh, Nepal, Kenya, and Uganda.

Read full story · Comments are closed

Mapping the Financial Flow and Expenditures for Select MNCH Medicines in Kenya

Since the report of the United Nations Commission on Life-Saving Commodities for Women and Children (UNCoLSC) was published in 2012, much has been done to highlight the challenges countries face in ensuring the availability of essential commodities and to create resources to assist countries in this endeavor. In most settings, these commodities are procured with government funds, but there is a lack of documented evidence as to how decisions regarding financing for these commodities are made and executed. An understanding of the financial flows for MNCH commodities is critical as countries pursue the goals of ending preventable child and maternal deaths and of universal health coverage and as many go through the process of decentralization. Understanding financial flows for MNCH commodities may also assist the donor community in making smarter investments and assisting countries in mobilizing additional resources. SIAPS conducted an assessment of subnational procurement practices in Kenya. One component of that assessment is related to understanding the financial flows for MNCH commodities.

Read full story · Comments are closed